Next Article in Journal
Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 Variants
Previous Article in Journal
Effectiveness of More Personalized, Case-Managed, and Multicomponent Treatment for Patients with Severe Schizophrenia Compared to the Standard Treatment: A Ten-Year Follow-Up
 
 
Article

Article Versions Notes

J. Pers. Med. 2022, 12(7), 1102; https://doi.org/10.3390/jpm12071102
Action Date Notes Link
article xml file uploaded 4 July 2022 13:21 CEST Original file -
article xml uploaded. 4 July 2022 13:21 CEST Update -
article pdf uploaded. 4 July 2022 13:21 CEST Version of Record -
article html file updated 4 July 2022 13:23 CEST Original file -
article xml file uploaded 4 July 2022 14:10 CEST Update -
article xml uploaded. 4 July 2022 14:10 CEST Update https://www.mdpi.com/2075-4426/12/7/1102/xml
article pdf uploaded. 4 July 2022 14:10 CEST Updated version of record https://www.mdpi.com/2075-4426/12/7/1102/pdf
article html file updated 4 July 2022 14:12 CEST Update -
article html file updated 13 August 2022 00:07 CEST Update https://www.mdpi.com/2075-4426/12/7/1102/html
Back to TopTop